Supplemental Material, Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183.R2 - Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible <i>Enterococcus</i> spp. Bloodstream Infections Jesse M. Fletcher Shawn J. Kram Christina B. Sarubbi Deverick J. Anderson Bridgette L. Kram 10.25384/SAGE.9801827.v1 https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183_R2_-_Effectiveness_of_Vancomycin_or_Beta-Lactam_Therapy_in_Ampicillin-Susceptible_i_Enterococcus_i_spp_Bloodstream_Infections/9801827 <p>Supplemental Material, Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183.R2 for Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible <i>Enterococcus</i> spp. Bloodstream Infections by Jesse M. Fletcher, Shawn J. Kram, Christina B. Sarubbi, Deverick J. Anderson and Bridgette L. Kram in Journal of Pharmacy Practice</p> 2019-09-11 10:06:17 bacteremia ampicillin infectious disease antibiotics endocarditis